DALPICICLIB

Clinical trials for DALPICICLIB explained in plain language.

Never miss a new study

Get alerted when new DALPICICLIB trials appear

Sign up with your email to follow new studies for DALPICICLIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug combo aims to keep early breast cancer from returning

Disease control Recruiting now

This study is testing whether adding the drug dalpiciclib to standard hormone therapy can help prevent breast cancer from coming back in women with early-stage HR+/HER2- breast cancer. About 2,000 women will receive either a higher dose for 2 years or a lower dose for 3 years, al…

Matched conditions: DALPICICLIB

Phase: PHASE2 • Sponsor: Fujian Cancer Hospital • Aim: Disease control

Last updated Jun 27, 2026 12:31 UTC

DALPICICLIB

Get alerted when new DALPICICLIB trials appear

New drug combo aims to keep early breast cancer from returning